TruWealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.02M Buy
36,369
+2
+0% +$53 0.05% 96
2025
Q4
$906K Sell
36,367
-1,421
-4% -$35.8K 0.04% 102
2025
Q3
$963K Sell
37,788
-1,488
-4% -$36.7K 0.05% 97
2025
Q2
$952K Buy
39,276
+2
+0% +$47 0.05% 92
2025
Q1
$995K Buy
39,274
+1
+0% +$26 0.06% 80
2024
Q4
$1.04M Sell
39,273
-308
-0.8% -$8.35K 0.06% 79
2024
Q3
$1.15M Buy
39,581
+1
+0% +$29 0.07% 78
2024
Q2
$1.11M Sell
39,580
-13
-0% -$358 0.07% 78
2024
Q1
$1.1M Sell
39,593
-1,032
-3% -$28.6K 0.08% 80
2023
Q4
$1.17M Sell
40,625
-210
-0.5% -$6.35K 0.09% 73
2023
Q3
$1.35M Sell
40,835
-772
-2% -$27.3K 0.12% 73
2023
Q2
$1.53M Sell
41,607
-1,576
-4% -$61.3K 0.13% 69
2023
Q1
$1.76M Sell
43,183
-1,388
-3% -$59.9K 0.16% 64
2022
Q4
$2.28M Buy
44,571
+1,453
+3% +$69.7K 0.22% 63
2022
Q3
$1.89M Buy
43,118
+1
+0% +$49 0.2% 61
2022
Q2
$2.26M Buy
43,117
+1,119
+3% +$57K 0.24% 54
2022
Q1
$2.17M Buy
41,998
+42
+0.1% +$2.18K 0.23% 54
2021
Q4
$2.48M Sell
41,956
-3
-0% -$149 0.25% 48
2021
Q3
$1.8M Sell
41,959
-149
-0.4% -$6.6K 0.2% 51
2021
Q2
$1.65M Buy
42,108
+783
+2% +$30.4K 0.19% 50
2021
Q1
$1.5M Sell
41,325
-752
-2% -$26.7K 0.2% 47
2020
Q4
$1.55M Buy
+42,077
New +$1.54M 0.23% 41

Other funds holding PFE

TruWealth Advisors's PFE Position: Q1 2026 in Review

TruWealth Advisors increased its Pfizer (PFE) stake by 0.01% in Q1 2026, buying an estimated $53 and bringing the position to 36,369 shares worth $1.02M. The position accounts for 0.05% of the portfolio, ranked #96.

TruWealth Advisors first reported a position in PFE in Q4 2020 and has held it in 22 quarters since. The position peaked at $2.48M in Q4 2021. 2,955 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • TruWealth Advisors held 36,369 shares of Pfizer worth $1.02M as of Q1 2026.
  • TruWealth Advisors bought 2 Pfizer shares in Q1 2026, an estimated $53.
  • Pfizer made up 0.05% of TruWealth Advisors's portfolio in Q1 2026, its #96 holding.
  • TruWealth Advisors first reported a position in Pfizer in Q4 2020 and has held it in 22 quarters since.
  • TruWealth Advisors's Pfizer position peaked at $2.48M in Q4 2021.
  • 2,955 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on TruWealth Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.